BA
52
3
ED
45
-4
AFL
66
2
FMC
39
2
ETN
79
7
AVY
50
3
INTU
47
3
COF
59
6
HPQ
49
3
HAS
51
2
KMI
61
4
CL
56
-2
TGT
47
5
GOOGL
59
3
DVN
39
4
IP
57
3
PGR
68
4
MAR
66
7
MTB
55
7
NEE
46
-4
BA
52
3
ED
45
-4
AFL
66
2
FMC
39
2
ETN
79
7
AVY
50
3
INTU
47
3
COF
59
6
HPQ
49
3
HAS
51
2
KMI
61
4
CL
56
-2
TGT
47
5
GOOGL
59
3
DVN
39
4
IP
57
3
PGR
68
4
MAR
66
7
MTB
55
7
NEE
46
-4
Financhill
Back

Brainstorm Cell Therapeutics Vs. Aprea Therapeutics Industry Stock Comparison

Sell
8

BCLI
Brainstorm Cell Therapeutics

Last Price:
2.23
Seasonality Move:
-7.58%
Sell
30

APRE
Aprea Therapeutics

Last Price:
2.60
Seasonality Move:
-39.53%
Sell
8
Brainstorm Cell Therapeutics (BCLI) is a Sell

Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?

  • The current Brainstorm Cell Therapeutics [BCLI] share price is $2.34. The Score for BCLI is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Aprea Therapeutics (APRE) is a Sell

Is Aprea Therapeutics a Buy, Sell or Hold?

  • The current Aprea Therapeutics [APRE] share price is $2.60. The Score for APRE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • APRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCLI Stock Price Chart

What is Brainstorm Cell Therapeutics's stock price today?

  • The Brainstorm Cell Therapeutics share price today is $2.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.

APRE Stock Price Chart

What is Aprea Therapeutics's stock price today?

  • The Aprea Therapeutics share price today is $2.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APRE is experiencing selling pressure, which indicates risk of future bearish movement.

BCLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.47 Sell
Relative Strength Index (14 RSI): 24.28 Sell
Chaikin Money Flow: -18150 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.17 - 4.27) Sell
Bollinger Bands (100): (3.91 - 6.79) Sell

APRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 33.15 Sell
Chaikin Money Flow: -13903 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.78 - 3.32) Sell
Bollinger Bands (100): (3.14 - 4.58) Sell

BCLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.15 Sell
20-day SMA: 3.59 Sell
50-day SMA: 4.27 Sell
200-day SMA: 5.74 Sell
8-day EMA: 3 Sell
20-day EMA: 3.5 Sell
50-day EMA: 4.22 Sell
200-day EMA: 7.23 Sell

APRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.73 Sell
20-day SMA: 2.96 Sell
50-day SMA: 3.31 Sell
200-day SMA: 4.86 Sell
8-day EMA: 2.74 Sell
20-day EMA: 2.94 Sell
50-day EMA: 3.3 Sell
200-day EMA: 4.5 Sell

Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.55 per share, and an increase next year of $0.08 per share.

Aprea Therapeutics Earnings Growth & APRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.21 per share, and an increase next year of $2.56 per share.

Brainstorm Cell Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aprea Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):